JOHN ABALLI - President and CEO, Director at EXAGEN INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
XGN on Nasdaq
All Insider Reports
All Insider Reports

JOHN ABALLI - trading volume in the past year for EXAGEN INC.

Holdings reported by JOHN ABALLI for EXAGEN INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 702,997 $2,537,819 $3.61 24 Feb 2026 Direct
Stock Option(right to buy) 75,000 $268,500 $3.58 21 Feb 2025 Direct Common Stock
Common Stock 40,401 $159,583 $3.95 24 Feb 2026 by Spouse

Transactions reported by JOHN ABALLI for EXAGEN INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.